Raymond James Financial’s SeaStar Medical ICU Stock Holding History

Raymond James Financial’s Portfolio ICU Stock Details ICU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,771	Closed	-$10.1K	–	5254
2025 Q3	$10.1K	Sell	1,771 -1,955	-52%	-$15.1K	﹤0.01%	4938
2025 Q2	$15.9K	Hold	3,726	–	–	﹤0.01%	5700
2025 Q1	$61.9K	Buy	+3,726	New	+$70.1K	﹤0.01%	4620

Other funds holding ICU

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TFA

Trinity Financial Advisors Columbus, Ohio $389M AUM 20.97% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DAS

Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TWP

Tyche Wealth Partners Plano, Texas $648M AUM 20.17% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial's ICU Position: Q4 2025 in Review

Raymond James Financial sold out of SeaStar Medical (ICU) in Q4 2025, closing a stake of 1,771 shares — an estimated $10.1K sold.

Raymond James Financial first reported a position in ICU in Q1 2025 and held it in 3 quarters. The position peaked at $61.9K in Q1 2025. 20 funds tracked by Wall St. Rank hold ICU as of Q4 2025.

Raymond James Financial reported no remaining SeaStar Medical position as of Q4 2025 after selling out during the quarter.
Raymond James Financial sold 1,771 SeaStar Medical shares in Q4 2025, an estimated $10.1K.
Raymond James Financial first reported a position in SeaStar Medical in Q1 2025 and held it in 3 quarters.
Raymond James Financial's SeaStar Medical position peaked at $61.9K in Q1 2025.
20 funds tracked by Wall St. Rank held SeaStar Medical as of Q4 2025.

Based on Raymond James Financial's 13F filing for Q4 2025, filed 18 Feb 2026.